“We are excited … to not only help employers provide innovative ways to better care for their employees, but also allow individuals the ability to understand genetically, how their body responds to medications,” WellVia CEO Steve Gaffney said.
Irving, Texas (PRWEB) August 02, 2017
WellVia, a premier virtual healthcare services company, announces the launch of WellVia Genetics, the first of its kind genetic testing with the flexibility and affordability provided via telemedicine. WellVia has partnered with Predictive Medical Solutions, a CLIA certified laboratory headquartered in Dallas, Texas, to offer an innovative and unique healthcare program that will provide employers with affordable access to industry leading pharmacogenetic (PGx) testing for their employees.
Through WellVia Genetics, employers and other organizations can offer DNA testing for their employees to assess the body’s ability to process medications thereby reducing potential adverse drug reactions.
According to a recent study published in Drugs & Aging (November 2016), there is evidence that utilizing pharmacogenetic tests provides the opportunity for an employer to reduce pharmaceutical costs by more than $600 per year per employee. Additionally, 53 percent of those individuals on polypharmacy were on the wrong drug or dosage, which in turn negatively impacted their performance on or off the job.
“We are excited about our expansion into pharmacogenetics and the opportunity to not only help employers provide innovative ways to better care for their employees, but also allow individuals the ability to understand genetically how their body responds to medications,” WellVia CEO Steve Gaffney said.
A simple cheek swab to gather an individual’s DNA will allow for the mapping of their unique genetic profile to the most commonly prescribed drugs based on diagnosis. WellVia Genetics will provide access to proven, industry-leading PGx tests that map to more than 2,500 different drugs, including over 40 percent of the most commonly prescribed drugs. These comprehensive tests map 19 different genes to identify mutations that may have an impact on how drugs are metabolized by the body.
“We are thrilled to be associated with WellVia to deliver state-of-the-art genetic testing to individuals across the United States. Through our partnership, we are now able to offer this cutting edge test to provide better medicine and a cost savings to the healthcare system,” Predictive Medical Solutions Managing Director Aparna Sharma said.
The pharmacogenetic testing solution will be available in August 2017, when WellVia’s proprietary technology platform will expand services to allow for a credentialed physician to request genetic tests for patients that qualify based on medical necessity for the tests to be performed.
Founded in 2014, WellVia is a premier virtual healthcare services company providing integrated healthcare solutions via telehealth. WellVia connects employers and consumers to a nationwide network of US Board Certified Physicians 24 hours a day, 7 days a week, within a matter of minutes. The company promotes Wellness ‘Via’ their cloud based proprietary platform and product offerings. The company believes every person deserves access to healthcare that is convenient, affordable, and easily accessible with exceptional care. For more information, visit http://www.WellViaGenetics.com or http://www.WellViaSolutions.com.
About Predictive Medical Solutions
Predictive Medical Solutions was founded with a singular vision in mind to bring cutting-edge diagnostic solutions with patient care at the core. Predictive Medical Solutions is proud to offer an array of state-of-the-art DNA and other diagnostic testing solutions. Predictive Medical Solutions was founded by physicians and a world-class healthcare team. With over 55 years of healthcare, business and legal experience, Predictive Medical Solutions prides itself on always placing the patient first.
Share article on social media or email:
Powered by WPeMatico